rs55730247
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_080680.3(COL11A2):c.2484+13delG variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0871 in 1,577,118 control chromosomes in the GnomAD database, including 10,475 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.098 ( 1219 hom., cov: 30)
Exomes 𝑓: 0.086 ( 9256 hom. )
Consequence
COL11A2
NM_080680.3 intron
NM_080680.3 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.49
Publications
5 publications found
Genes affected
COL11A2 (HGNC:2187): (collagen type XI alpha 2 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. It is located on chromosome 6 very close to but separate from the gene for retinoid X receptor beta. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Proteolytic processing of this type XI chain produces PARP, a proline/arginine-rich protein that is an amino terminal domain. Mutations in this gene are associated with type III Stickler syndrome, otospondylomegaepiphyseal dysplasia (OSMED syndrome), Weissenbacher-Zweymuller syndrome, autosomal dominant non-syndromic sensorineural type 13 deafness (DFNA13), and autosomal recessive non-syndromic sensorineural type 53 deafness (DFNB53). Alternative splicing results in multiple transcript variants. A related pseudogene is located nearby on chromosome 6. [provided by RefSeq, Jul 2009]
COL11A2 Gene-Disease associations (from GenCC):
- autosomal dominant nonsyndromic hearing loss 13Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
- nonsyndromic genetic hearing lossInheritance: AD, AR Classification: DEFINITIVE, MODERATE Submitted by: ClinGen
- otospondylomegaepiphyseal dysplasia, autosomal dominantInheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: PanelApp Australia, Ambry Genetics, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- autosomal recessive nonsyndromic hearing loss 53Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- otospondylomegaepiphyseal dysplasiaInheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- otospondylomegaepiphyseal dysplasia, autosomal recessiveInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- autosomal dominant nonsyndromic hearing lossInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- fibrochondrogenesisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
BP6
Variant 6-33174151-AC-A is Benign according to our data. Variant chr6-33174151-AC-A is described in ClinVar as Benign. ClinVar VariationId is 262308.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.5 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| COL11A2 | NM_080680.3 | c.2484+13delG | intron_variant | Intron 32 of 65 | ENST00000341947.7 | NP_542411.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL11A2 | ENST00000341947.7 | c.2484+13delG | intron_variant | Intron 32 of 65 | 5 | NM_080680.3 | ENSP00000339915.2 | |||
| COL11A2 | ENST00000374708.8 | c.2226+13delG | intron_variant | Intron 30 of 63 | 5 | ENSP00000363840.4 | ||||
| COL11A2 | ENST00000361917.6 | c.1056+13delG | intron_variant | Intron 19 of 23 | 5 | ENSP00000355123.2 | ||||
| COL11A2 | ENST00000477772.1 | n.272+2857delG | intron_variant | Intron 5 of 8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0980 AC: 14398AN: 146962Hom.: 1208 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
14398
AN:
146962
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.105 AC: 21532AN: 204660 AF XY: 0.102 show subpopulations
GnomAD2 exomes
AF:
AC:
21532
AN:
204660
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0860 AC: 122965AN: 1430048Hom.: 9256 Cov.: 37 AF XY: 0.0850 AC XY: 60306AN XY: 709532 show subpopulations
GnomAD4 exome
AF:
AC:
122965
AN:
1430048
Hom.:
Cov.:
37
AF XY:
AC XY:
60306
AN XY:
709532
show subpopulations
African (AFR)
AF:
AC:
3063
AN:
32420
American (AMR)
AF:
AC:
3308
AN:
42336
Ashkenazi Jewish (ASJ)
AF:
AC:
1194
AN:
25570
East Asian (EAS)
AF:
AC:
19730
AN:
37814
South Asian (SAS)
AF:
AC:
6571
AN:
82362
European-Finnish (FIN)
AF:
AC:
3894
AN:
50766
Middle Eastern (MID)
AF:
AC:
403
AN:
5706
European-Non Finnish (NFE)
AF:
AC:
79280
AN:
1093898
Other (OTH)
AF:
AC:
5522
AN:
59176
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
6441
12882
19324
25765
32206
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
3184
6368
9552
12736
15920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0980 AC: 14416AN: 147070Hom.: 1219 Cov.: 30 AF XY: 0.100 AC XY: 7194AN XY: 71734 show subpopulations
GnomAD4 genome
AF:
AC:
14416
AN:
147070
Hom.:
Cov.:
30
AF XY:
AC XY:
7194
AN XY:
71734
show subpopulations
African (AFR)
AF:
AC:
4010
AN:
39528
American (AMR)
AF:
AC:
1286
AN:
14848
Ashkenazi Jewish (ASJ)
AF:
AC:
150
AN:
3394
East Asian (EAS)
AF:
AC:
2599
AN:
5036
South Asian (SAS)
AF:
AC:
425
AN:
4562
European-Finnish (FIN)
AF:
AC:
900
AN:
10100
Middle Eastern (MID)
AF:
AC:
32
AN:
292
European-Non Finnish (NFE)
AF:
AC:
4715
AN:
66364
Other (OTH)
AF:
AC:
251
AN:
2050
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
604
1208
1811
2415
3019
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
160
320
480
640
800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
829
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:2
Jan 08, 2016
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
May 30, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Otospondylomegaepiphyseal dysplasia, autosomal dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Otospondylomegaepiphyseal dysplasia, autosomal recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Fibrochondrogenesis 1 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Stickler Syndrome, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.